Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Pathology|July 20, 2017
Loss of the tumour suppressor gene AIP mediates the browning of human brown fat tumoursLinda Magnusson, Nils Hansen, Karim H Saba, et al.
Genes, Chromosomes & Cancer|September 20, 2022
Inactivation of RB1, CDKN2A, and TP53 have distinct effects on genomic stability at side-by-side comparison in karyotypically normal cellsNatalie Andersson, Karim H Saba, Linda Magnusson, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 6, 2023
Osteosarcomas With Few Chromosomal Alterations or Adult Onset Are Genetically HeterogeneousValeria Difilippo, Karim H Saba, Emelie Styring, et al.
The Journal of Pathology. Clinical Research|February 6, 2020
NTRK fusions in osteosarcoma are rare and non-functional eventsBaptiste Ameline, Karim H Saba, Michal Kovac, et al.
Biochimica Et Biophysica Acta. Biomembranes|October 10, 2021
Aquaglyceroporins and orthodox aquaporins in human adipocytesPeng Huang, Jesper S Hansen, Karim H Saba, et al.
Genes, Chromosomes & Cancer|May 9, 2019
Genetic profiling of a chondroblastoma-like osteosarcoma/malignant phosphaturic mesenchymal tumor of bone reveals a homozygous deletion of CDKN2A, intragenic deletion of DMD, and a targetable FN1-FGFR1 gene fusionKarim H Saba, Louise Cornmark, Marianne Rissler, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2023
Identification of COL1A1/2 Mutations and Fusions With Noncoding RNA Genes in Bizarre Parosteal Osteochondromatous Proliferation (Nora Lesion)Yu-Chien Kao, Akihiko Yoshida, Tsung-Han Hsieh, et al.
NPJ Genomic Medicine|September 25, 2024
CDK4 is co-amplified with either TP53 promoter gene fusions or MDM2 through distinct mechanisms in osteosarcomaKarim H Saba, Valeria Difilippo, Emelie Styring, et al.
Nature Communications|February 7, 2020
Clonal competition within complex evolutionary hierarchies shapes AML over timeCarl Sandén, Henrik Lilljebjörn, Christina Orsmark Pietras, et al.
The Journal of Pathology|November 27, 2023
Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathwayKarim H Saba, Valeria Difilippo, Michal Kovac, et al.
Pageof 2